The Fraxel re:fine is the next generation Fraxel Laser . It is a 1410nm laser which offers an additional choice in non-invasive skin rejuvenation by combining a more superficially absorbed laser wavelength with the unique fractional technology. It is FDA approved for the treatment of pigmented lesions, periorbital fine lines, melasma, and skin resurfacing leading to an improvment in skin texture, tone, pigmentation and fine lines with minimal patient downtime or discomfort. Most patients will require 4-6 treatments at 2-3 week intervals to achieve maximum results.